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ABSTRACT
Prions are a particular type of amyloids with the abil-
ity to self-perpetuate and propagate in vivo. Prion-
like conversion underlies important biological pro-
cesses but is also connected to human disease.
Yeast prions are the best understood transmissible
amyloids. In these proteins, prion formation from an
initially soluble state involves a structural conver-
sion, driven, in many cases, by specific domains en-
riched in glutamine/asparagine (Q/N) residues. Im-
portantly, domains sharing this compositional bias
are also present in the proteomes of higher or-
ganisms, thus suggesting that prion-like conversion
might be an evolutionary conserved mechanism. We
have recently shown that the identification and evalu-
ation of the potency of amyloid nucleating sequences
in putative prion domains allows discrimination of
genuine prions. PrionW is a web application that ex-
ploits this principle to scan sequences in order to
identify proteins containing Q/N enriched prion-like
domains (PrLDs) in large datasets. When used to
scan the complete yeast proteome, PrionW identifies
previously experimentally validated prions with high
accuracy. Users can analyze up to 10 000 sequences
at a time, PrLD-containing proteins are identified and
their putative PrLDs and amyloid nucleating cores vi-
sualized and scored. The output files can be down-
loaded for further analysis. PrionW server can be ac-
cessed at http://bioinf.uab.cat/prionw/.
INTRODUCTION
Prions are a class of proteins that can exist in at least two
conformations, one of which is an amyloid state that is
self-propagating and hence infectious as it can induce the
conversion of identical protein sequences from the non-
prion conformation to the amyloid state (1). Although pri-
ons were discovered through the example of the human
pathogen PrP (2), a host of functional prions have since
been discovered, predominantly in fungi (3,4). Importantly,
the distinction between prion proteins and other proteins
capable of forming amyloids is blurring, notably in human
diseases such as Alzheimer’s or Parkinson’s, as it has been
observed that amyloids of the proteins involved in these dis-
eases are capable of seeding amyloid formation of the solu-
ble form of these proteins, both in vitro and in vivo labora-
tory conditions (5,6). Given that there is no epidemiological
evidence that these amyloidogenic proteins are spreading in
natural systems, the group has been called prion-like or ‘pri-
onoid’ (1). This raises the question of what sequence deter-
minants characterize a functional prion beyond mere amy-
loid propensity. A subset of prions, not including PrP, are
multidomain proteins containing both globular domains
and, usually, one Prion Forming Domain (PFD) enriched
in glutamine and asparagine (Q/N) residues that under-
goes the structural rearrangement during prion conversion
(7). Most known yeast prions, but not all, share this archi-
tecture. The sequence features of these PFDs overlap with
those of intrinsically disordered regions (DRs) (8). It has
been proposed that in contrast to the short stretches that
are known to be sufficient to nucleate amyloid formation,
Q/N based yeast prions have more diffuse nuclei, charac-
terized by a large number of weak interactions between the
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side-chains of the PFD (9,10). However, we have demon-
strated that the superimposition of an intrinsically disor-
dered sequence region containing ‘classical’ amyloid nucle-
ating sequences in fact yields a more accurate classifica-
tion of experimental prions from related Q/N-enriched se-
quences (11). In the current paper, we provide public access
to our method by way of a webserver.
METHOD
PrionW allows scanning individual protein sequences for
the presence of putative Q/N rich PFDs, as well as the scan-
ning of large protein datasets (up to 10 000 sequences) for
proteomic analysis. The method behind PrionW assumes
that in order to be a PFD a protein sequence should ful-
fill the following requirements: (i) contain a specific stretch
with significant amyloid propensity, able to selectively nu-
cleate self-assembly into ordered, but brittle, amyloid struc-
tures, (ii) have a disordered structural context that read-
ily permits self-assembly without requiring conformational
unfolding and (iii) have an amino acid composition that
allows the domain to be soluble at the physiological con-
centrations required for protein function yet display a basal
amyloid propensity, to which N and Q residues would con-
tribute significantly, promoting domain assembly in the
presence of preformed amyloid seeds or when the concen-
tration is increased.
PrionW analyses whether a given protein or protein frag-
ment satisfies the above requirements in three sequential
steps:
1. Identification of DRs in protein sequences: PrionW ana-
lyzes protein sequences to identify the presence of intrin-
sically DRs by implementing FoldIndex (12) with the de-
fault 51-aa window size. Only disordered segments of at
least 60 contiguous residues are further evaluated, since
this core size seems to suffice to attain a prion-like behav-
ior in Q/N rich PFDs (13). When a protein contains two
or more DRs, these regions are subsequently evaluated
individually.
2. Evaluation of Q/N enrichment: The proportion of Q +
N residues in the detected DRs is calculated. The pro-
gram moves through each individual sequence by single
amino acid steps looking for the longer stretch of adja-
cent residues having a Q/N proportion ≥ than a given
threshold in the predicted disordered region. The default
is set at ≥ 25% of Q/N residues, because the PFDs of
most experimentally characterized yeast prions fulfill this
requirement (13,14). However, since Q/N enrichment for
prion-like formation might change from organism to or-
ganism the user can select the minimum Q/N content.
If the threshold is set to 0% the program identifies only
DRs.
3. Amyloid core identification and scoring: The individual
sequences fulfilling the requirements in steps 1 and 2 are
further evaluated for the presence of a 21-residue long
amyloid core able to specifically nucleate its self-assembly
according to the pWALTZ scoring function (11), an up-
date of the scoring function in our well-established amy-
loid predictor WALTZ (15). The default pWALTZ cut-
off in PrionW was set to 73.55, since this value pro-
vided the best accuracy for the discrimination of experi-
mentally validated putative yeast PFDs from sequences
displaying similar Q/N content but devoid of priono-
genic potential (see Performance). A lower cut-off can
be useful to identify sequences in genomes with a basal
prion propensity (16). Accordingly, the user can select the
pWALTZ cut-off in the 50–75 value range. pWALTZ val-
ues lower than 50.0 are not allowed because they do not
permit discrimination of prion and non prion sequences
in the yeast dataset used for parameterization, since the
accuracy of PrionW in these conditions is below 50% and
the Matthews correlation coefficient (MCC) below 0.4
(Figure 1). For a given protein sequence, the disordered
Q/N rich region containing the highest-scoring amyloid
core is selected as the putative PFD or Prion-like domain
(PrLD) in this protein, as long as it passes the selected
threshold.
PERFORMANCE
Yeast prions constitute ideal model systems to character-
ize prion-like behavior. On the basis of compositional sim-
ilarity to known prions, Lindquist’s group used a hidden
Markov model (HMM) to identify 100 prion candidates in
the yeast genome (13). They scored 92 of them from 0 to 10
according to their performance in four different experimen-
tal assays for both amyloid and prion forming ability, higher
scores indicating more prionogenic sequences. It turned out
that in this, in principle, prion enriched set, only 13% of the
proteins scored≥ 9 whereas 42% scored≤ 2, demonstrating
the extreme difficulty to discriminate prions fromnonprions
when they all share a similar Q/N enriched compositional
context. The HMM predicted PFDs of these proteins were
used to build up a dataset in which we considered as non-
prions (negatives) those sequences scoring ≤ 2 and being
positive in one assay at maximum (39 sequences), because
it means that they do not exhibit amyloid and prion form-
ing ability at the same time, and prions (positives) those do-
mains being positive in all four assays and scoring≥ 9, with
a total of 12 sequences, including the actual prions New1,
Rnq1, Swi1, Sup35 and Ure2 proteins, defined as those
proteins that act as prions in its natural context, increas-
ing population-level phenotypic heterogeneity (11) (Supple-
mentary Table S1). We speculated that the presence and
the strength of short amyloid cores embedded in these do-
mains might account for their different prionogenic poten-
tial. This concept was implemented in the pWALTZ scoring
function, allowing discrimination between positive and neg-
ative PFDs in the above-mentioned 51-protein dataset with
better accuracy than approaches based only on composition
(11).
Despite its accuracy, a serious limitation of pWALTZ
to analyze large protein datasets is that it needs to work
on top of dissected putative PFDs sequences, because the
folded domains adjacent to these regions and, more gener-
ally, globular proteins usually contain one or more amyloid
regions (17), whose high aggregation potency would blur
any prediction. PrionW tries to solve this issue by consid-
ering the structural disorder and Q/N compositional bias
characteristic of most yeast PFDs.
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Figure 1. Accuracy and MCC cut-off plot for PrionW. (A) Accuracy, in percentage, and (B) Matthews correlation coefficient (MCC) obtained for the
correct classification of TP and TN is graphed against increasing pWALTZ cut-offs. We highlight the highest accuracy and MCC of the assay, used to set
the predictive cut-off of 73.55.
In our previous work, a 73.55 pWALTZ cut-off provided
the best accuracy to discriminate prions from nonprions
(11); however, this value resulted from the analysis of the
PFDs identified by the Lindquist’s groupHMM,whichmay
or may not coincide with those sequences identified by Pri-
onW on the basis of structural disorder and Q/N content
for their further pWALTZ assessment (see Methods). Thus,
to parameterize PrionW, we analyzed the 6719 proteins en-
coded in the Saccharomyces cerevisiae S288c reference pro-
teome for the presence of PrLDs using a fixed Q/N con-
tent ≥ 25% and gradually increasing the pWALTZ cut-off
from 35 to 90% in 0.1% steps. The accuracy of the method
was calculated at each stringency level by evaluating the
presence of positive and negative instances from the orig-
inal 51-protein dataset (Supplementary Table S1) in the re-
turned proteome predictions (Figure 1A). The best predic-
tions were obtained with cut-offs ranging from 73.50 to
73.60, suggesting that the disordered Q/N rich domains
identified by PrionW might overlap with the PFDs identi-
fied using the HMM. We also calculated the MCC associ-
ated at the prediction at each stringency level (Figure 1B).
Again the best correlations were obtained in the 73.50–
73.60 range. Accordingly, a 73.55 cut-off was selected as
the default pWALTZ value in PrionW. The performance of
the predictions is maintained at any Q + N richness in the
≥ 20% to ≥ 35% range. Using a Q/N content ≥ 25% and
a 73.55 pWALTZ cut-off, PrionW returned a total of 63
predictions (Supplementary Table S2). They included 92%
of the previously considered positives (11 sequences), only
Puf2 being missing. In contrast, only 5% of the negative
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ones (two sequences) were recovered. This corresponds to
a sensitivity of 0.917, a specificity of 0.949, a precision of
0.846, an accuracy of 0.941 and a false discovery rate of only
0.154. These values (Table 1) indicate that our methodology
produce fairly clean recovery sets with a rather low propor-
tion of false positives. If we consider as positive sequences
only the set of actual Q/N-rich prions: Cyc8, Mot3, New1,
Rnq1, Sfp1, Swi1, Sup35 and Ure2, PrionW is able to re-
cover the large majority of them from the yeast proteome
with the default settings, missing only Cyc8.
Two pioneering works addressed previously the discovery
of potential novel prion-forming proteins exploiting their
Q/N bias. Michelitsch and Weissman developed DIANA
(Defined Interval Amino acid Numerating Algorithm), an
algorithm aimed to identify proteins containing regions of
consecutive amino acids with exceptionally high Q/N con-
tent (18). The screening of the yeast proteome with this ap-
proach rendered a total of 107 predictions, which include
11 of the positive sequences but also 24 of the negative
ones (Supplementary Table S3). Thirty three proteins pre-
dicted by PrionW are also present in the DIANA dataset
(Supplementary Table S4). Harrison and Gerstein derived
a method for identifying biased regions that relies on defin-
ing the lowest-probability subsequences (LPSs) for a given
amino-acid composition and applied this formalism to ana-
lyze the prevalence ofQ- andN-rich regions in different pro-
teomes (19). This method identifies 172 prion-like Q/N-rich
regions in yeast, which include all the 12 positive sequences
but also 34 of the negative ones (Supplementary Table S5).
Thirty five proteins predicted by PrionW are also present
in the LPS dataset (Supplementary Table S6). A compari-
son of the performance of PrionW, with that of the DIANA
and LPSs approaches (Table 1), illustrates the usefulness of
evaluating the presence and potency of short amyloidogenic
regions in the context of Q/Nrich sequences to discriminate
prionogenic sequences in complete proteomes.
The ability to perform predictions in complete proteomes
allows using Gene Ontology (GO) annotations to clas-
sify proteins containing PrLDs according cellular locations,
functional classes and processes, uncovering the role played
by these polypeptides in the cell. According to the GO clas-
sification in the Sacharomyces Genome Database (SGD)
(http://www.yeastgenome.org) the detected proteins are as-
sociated to cytoplasmatic ribonucleoprotein granules (P =
4.1 × 10−05) and nucleus (P = 6.1 × 10−05), their preferen-
tial function is mRNA binding (P= 3.0 × 10−05) and more
generally nucleic acid binding (P = 6.3 × 10−03) and they
work in the regulation of biological processes (P = 5.9 ×
10−07) andmore specifically in the regulation of gene expres-
sion (P = 7.7 × 10−06). This analysis highlight the impor-
tant role played by PrLDs-containing proteins in the yeast
physiology, a role that might be also exerted in higher or-
ganisms.
According to FoldIndex and other disorder predictors
like RONN (20) or FoldUnfold (21), in most of the 62 hits,
the detected PrLDs are accompanied by at least a folded do-
main, which is likely the responsible of the protein activity
and probably widely offset from the fibril backbone in the
amyloid state (22). As expected, in contrast to pWALTZ,
PrionW can identify genuine prions even when their PFDs
represent a small fraction in the complete sequence of an es-
sentially folded protein (Figure 2). PrionW is not intended
to delimit the exact boundaries in the identified PrLDs;
however, the best overlap between Uniprot annotated prion
domains for actual yeast prions and PrionW predictions
was obtained when Q + N richness was set to ≥ 32% (Sup-
plementary Table S2).
The requirement to tune theQ+N content and pWALTZ
parameters when using PrionW to screen for prion-like pro-
teins in proteomes different from that of yeast is best illus-
trated by the fact that the algorithm is not able to iden-
tify a set of human proteins that have been proposed to
display prion-like behavior (8), including hnRNPA1, hn-
RNPA2, hnRNPA3, hnRNPDL, SS18L1/CREST, FUS,
EWS, TAF15 and TPD43 with the default settings. How-
ever, setting theQ/Ncontent at≥15% and pWALTZ cut-off
at 64.00 allows retrieving them, except TDP43, and iden-
tifying their putative amyloid cores (Supplementary Table
S7). The overall lower amyloidogenic potential of the pre-
dicted nucleating cores of those human prion-like proteins
could respond to the fact they might not be actual prions,
but rather proteins able to self-assemble reversibly for func-
tional purposes (8) and, even if they have been shown to
form intracellular aggregates upon mutation (16), their as-
semblies are generally softer than those of actual yeast pri-
ons (23) and it is not evident that they can be propagated as
bona fide prions.
SERVER DESCRIPTION
The PrionW webserver does not require any user registra-
tion or identification. The interface can process up to 10 000
sequences at a time.
Input interface
PrionW is presented as an application running in a single
web page (Figure 3). One or more sequences in FASTA for-
mat must be pasted in the text box or uploaded as a file.
Two algorithm parameters can be tuned by the user: ‘Q +
N richness’ defines the minimum proportion of Q and N
residues a disordered region should have to be further con-
sidered; ‘pWaltz cut off’ defines the minimum pWaltz score
for an amyloid core to be considered positive. Default val-
ues are otherwise assigned to these parameters (seemethods
for more details). The web page displays four links in its up-
per margin: (i) reference publications of methods and web
application, (ii) a contact mail, (iii) a help with a short de-
scription of the algorithm, input instructions, output expla-
nation and information on examples and (iv) examples that
will populate the input text area with full-length sequences
of the well-characterized yeast prions New1, Rnq1, Swi1,
Sup35 and Ure2 and a set of prion positive and negative
control synthetic sequences proposed by Toombs et al. (10).
Output
When clicking the submit button the input frame changes.
After checking for the correct FASTA format, a header
showing the number of interpreted sequences, input param-
eters and job identifier (to be used in questions to the au-
thors) appears. After the calculation has finished, a link to
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Table 1. Performance of DIANA, LPSs and PrionW approaches in the prediction of experimental yeast prion-like proteins (protein dataset in Supple-
mentary Table S1)
DIANA LPSs PrionW
Sensitivity 0.917 1 0.917
Specificity 0.385 0.128 0.949
Precision 0.314 0.261 0.846
FDRa 0.686 0.739 0.154
Accuracy 0.510 0.333 0.941
MCCb 0.275 0.183 0.842
aFalse Discovery Rate.
bMatthews correlation coefficient.
The best value for each parameter is indicated in bold.
Figure 2. PrionW predictions of prion-like domains (PrLDs) and amyloid cores in the sequences of the genuine yeast prions New1, Ure2 and Rnq1. Folded
domains, disordered regions, predicted PrLDs and amyloid cores are shown in white, green, blue and red, respectively.
a CSV file containing the output data are provided. Below
the header, positive hits are printed in the same order as
they were submitted. For each hit, the name, the predicted
21-residue amyloid core, the pWaltz score and the predicted
Q/N rich PrLDwith the amyloid core highlighted in red are
presented (Figure 3). If no positive sequences are detected
in the input dataset the algorithm returns the followingmes-
sage: ‘None of your sequences contains a predicted Prion-
likeDomain.’ TheCSVfile contains all thementioned infor-
mation, which will be kept in our server for 7 days. If the al-
gorithm detects a format error in the input sequences, an in-
put parameter out of range, a number of sequences exceed-
ing the maximum allowed or an engine problem, the pro-
gram execution stops and a brief explanation of the prob-
lem is given.
Implementation and server run-time
The PrionW web server runs on an engine implementing
the algorithm described in methods. It has been written in
python and uses python2.7 as the interpreter. Theweb inter-
face has been build using html/css and inputs and outputs
are processed by a cgi written in perl. It all runs in a CentOS
5 server with Apache 2.2.3 using Intel Xeon ‘Clovertown’
processors. The execution time for processing the complete
S. cerevisiae S288c reference proteome in our server was
lower than 5 min.
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Figure 3. Screen shots of the PrionW web server. Upper panel shows web page input populated with example sequences and algorithm parameters in
default values. Lower panel shows the returned results for these sequences.
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CONCLUSION
We have described PrionW, a web server for the prediction
of proteins containing Q/N rich prion-like domains and
their amyloid cores in large sequence datasets. The algo-
rithm should find application in the discovery of new candi-
dates in different organisms for further experimental char-
acterization, in the identification of mutations endorsing
wild-type proteins with increased prion-like properties, in
the design of synthetic prion domains for different purposes
or in the design and synthesis of short peptides correspond-
ing to PrLDs amyloid cores able to seed the aggregation of
the complete protein and, more generally, in understanding
prion function and regulation in different species.
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